The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia

Clinical Neurophysiology

Volumn 125, Issue 8, 2014, Pages 1509-1532

  Cantone, Mariagiovanna ^a   Di Pino, Giovanni ^a,b   Capone, Fioravante ^a,b   Piombo, Marianna ^a,b   Chiarello, Daniela ^a,b   Cheeran, Binith ^c   Pennisi, Giovanni ^d   Di Lazzaro, Vincenzo ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Fondazione Alberto Sordi   (Italy)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Brain stimulation; Cognitive dysfunction; Cortical excitability; Differential diagnosis; Intracortical circuitry; Motor impairment; Neuromodulation

Indexed keywords

AMANTADINE; BACLOFEN; BROMOCRIPTINE; CARBIDOPA; CLONAZEPAM; DIAZEPAM; DONEPEZIL; GALANTAMINE; HYDROXYZINE; LEVODOPA; NEUROLEPTIC AGENT; RIVASTIGMINE; SULPIRIDE; TETRABENAZINE; TIAPRIDE; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT; ACETYLCHOLINE; NEUROTRANSMITTER RECEPTOR;

ALZHEIMER DISEASE; CORTICOBASAL DEGENERATION; CREUTZFELDT JAKOB DISEASE; DEMENTIA; EVOKED MUSCLE RESPONSE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; MULTIINFARCT DEMENTIA; NORMOTENSIVE HYDROCEPHALUS; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SHY DRAGER SYNDROME; TRANSCRANIAL MAGNETIC STIMULATION; BRAIN CORTEX; COMPLICATION; DEMENTIA, VASCULAR; DIFFERENTIAL DIAGNOSIS; LEWY BODY DISEASE; METABOLISM; MILD COGNITIVE IMPAIRMENT; MULTIPLE SYSTEM ATROPHY; NERVE CELL PLASTICITY; PROCEDURES; SUPRANUCLEAR PALSY, PROGRESSIVE;

ACETYLCHOLINE; ALZHEIMER DISEASE; CEREBRAL CORTEX; DEMENTIA; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FRONTOTEMPORAL DEMENTIA; HUMANS; LEWY BODY DISEASE; MILD COGNITIVE IMPAIRMENT; MULTIPLE SYSTEM ATROPHY; NEURONAL PLASTICITY; PARKINSON DISEASE; RECEPTORS, NEUROTRANSMITTER; SUPRANUCLEAR PALSY, PROGRESSIVE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84904059447     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2014.04.010     Document Type: Review

References (226)

1. Abbruzzese G., Buccolieri A., Marchese R., Trompetto C., Mandich P., Schieppati M. Intracortical inhibition and facilitation are abnormal in Huntington's disease: a paired magnetic stimulation study. Neurosci Lett 1997, 228:87-90.
2. Abbruzzese G., Marchese R., Trompetto C. Sensory and motor evoked potentials in multiple system atrophy: a comparative study with Parkinson's disease. Mov Disord 1997, 12:315-321.
3. Abele M., Schulz J., Bürk K., Topka H., Dichgans J., Klockgether T. Evoked potentials in multiple systematrophy (MSA). Acta Neurol Scand 2000, 101:111-115.
4. Adams R., Fisher C., Hakim S., Ojemann R., Sweet W. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure: a treatable syndrome. N Engl J Med 1965, 273:117-126.
5. Ahmed M.A., Darwish E.S., Khedr E.M., Ali A.M. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia. J Neurol 2012, 259:83-92.
6. Alagona G., Bella R., Ferri R., Carnemolla A., Pappalardo A., Costanzo E., et al. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci Lett 2001, 314:57-60.
7. Alagona G., Ferri R., Pennisi G., Carnemolla A., Maci T., Domina E., et al. Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia. Neurosci Lett 2004, 362:95-98.
8. Alberici A., Bonato C., Calabria M., Agosti C., Zanetti O., Miniussi C., et al. The contribution of TMS to frontotemporal dementia variants. Acta Neurol Scand 2008, 118:275-280.
9. Annweiler C., Beauchet O., Bartha R., Wells J.L., Borrie M.J., Hachinski V., et al. Motor cortex and gait in mild cognitive impairment: a magnetic resonance spectroscopy and volumetric imaging study. Brain 2013, 136:859-871.
10. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991, 1:103-116.
11. Arrighi H.M., Gélinas I., Gauthier S., McLaughlin T., Black R., Grundman M. Longitudinal changes in functional disability in Alzheimer's disease patients. Alzheimer's Dement 2010, 6:3.
12. Association AP, DSM-IV. APATFo. Diagnostic and statistical manual of mental disorders: DSM-IV. Amer Psychiatric Pub Inc; 1994.
13. Atanassova P., Chalakova N., Goranov S., Ilieva E., Sotirova K., Massaldjieva R. A case of encephalomyelopolyneuropathy in vitamin B12 deficiency. Folia Med 2004, 46:52.
14. Avanzino L., Marinelli L., Buccolieri A., Trompetto C., Abbruzzese G. Creutzfeldt-Jakob disease presenting as corticobasal degeneration: a neurophysiological study. Neurol Sci 2006, 27:118-121.
15. Aydin-Abidin S., Trippe J., Funke K., Eysel U.T., Benali A. High-and low-frequency repetitive transcranial magnetic stimulation differentially activates c-Fos and zif268 protein expression in the rat brain. Exp Brain Res 2008, 188:249-261.
16. Barr M.S., Farzan F., Rajji T.K., Voineskos A.N., Blumberger D.M., Arenovich T., et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol Psychiatry 2013, 73:510-517.
17. Battaglia F., Quartarone A., Bagnato S., Rizzo V., Morgante F., Floccari F., et al. Brain dysfunction in uremia: a question of cortical hyperexcitability?. Clin Neurophysiol 2005, 116:1507-1514.
18. Battaglia F., Wang H.-Y., Ghilardi M.F., Gashi E., Quartarone A., Friedman E., et al. Cortical plasticity in Alzheimer's disease in humans and rodents. Biol Psychiatry 2007, 62:1405-1412.
19. Bella R., Ferri R., Lanza G., Cantone M., Pennisi M., Puglisi V., et al. TMS follow-up study in patients with vascular cognitive impairment-no dementia. Neurosci Lett 2013, 534:155-159.
20. Bella R., Ferri R., Pennisi M., Cantone M., Lanza G., Malaguarnera G., et al. Enhanced motor cortex facilitation in patients with vascular cognitive impairment-no dementia. Neurosci Lett 2011, 503:171-175.
21. Bentwich J., Dobronevsky E., Aichenbaum S., Shorer R., Peretz R., Khaigrekht M., et al. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study. J Neural Transm 2011, 118:463-471.
22. Bonnì S, Lupo F, Lo Gerfo E, Martorana A, Perri R, Caltagirone C, et al. Altered parietal-motor connections in Alzheimer's disease patients. J Alzheimer's Dis 2013a;33:525-33.
23. Bonnì S, Lupo F, Lo Gerfo E, Martorana A, Perri R, Caltagirone C, et al. Altered parietal-motor connections in Alzheimer's disease patients. J Alzheimers Dis 2013b;33:525-33.
24. Brem A.-K., Atkinson N.J., Seligson E.E., Pascual-Leone A. Differential pharmacological effects on brain reactivity and plasticity in Alzheimer's disease. Front Psychiatry 2013, 4:124.
25. Brem A-K, Atkinson NJ, Seligson EE, Pascual-Leone A. Differential pharmacological effects on brain reactivity and plasticity in Alzheimer's disease. Front Psychiatry 2013b;4.
26. Brusa L., Ponzo V., Mastropasqua C., Picazio S., Bonnì S., Di Lorenzo F., et al. Theta burst stimulation modulates cerebellar-cortical connectivity in patients with progressive supranuclear palsy. Brain Stimul 2014, 7:29-35.
27. Burrell J.R., Kiernan M.C., Vucic S., Hodges J.R. Motor neuron dysfunction in frontotemporal dementia. Brain 2011, 134:2582-2594.
28. Cantello R, Gianelli M, Bettucci D, Civardi C, De Angelis M, Mutani R. Parkinson's disease rigidity Magnetic motor evoked potentials in a small hand muscle. Neurology 1991; 41: 1449.
29. Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation The silent period after the motor evoked potential. Neurology 1992; 42: 1951.
30. Celebi O., Temuçin C.M., Elibol B., Saka E. Short latency afferent inhibition in Parkinson's disease patients with dementia. Mov Disord 2012, 27:1052-1055.
31. Cheeran B., Koch G., Stagg C., Baig F., Teo J. Transcranial magnetic stimulation: from neurophysiology to pharmacology, molecular biology and genomics. The Neuroscientist 2010, 16:210-221.
32. Chen R., Cros D., Curra A., Di Lazzaro V., Lefaucheur J.-P., Magistris M.R., et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 2008, 119:504-532.
33. Chen R., Lozano A.M., Ashby P. Mechanism of the silent period following transcranial magnetic stimulation evidence from epidural recordings. Exp Brain Res 1999, 128:539-542.
34. Chibbaro G., Daniele M., Alagona G., Di Pasquale C., Cannavò M., Rapisarda V., et al. Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations. Neurosci Lett 2005, 383:54-57.
35. Chistyakov A.V., Hafner H., Sinai A., Kaplan B., Zaaroor M. Motor cortex disinhibition in normal-pressure hydrocephalus: clinical article. J Neurosurg 2012, 116:453-459.
36. Compta Y., Parkkinen L., Kempster P., Selikhova M., Lashley T., Holton J.L., et al. The significance of α-synuclein, amyloid-β and tau pathologies in Parkinson's disease progression and related dementia. Neurodegener Dis 2014, 13:154-156.
37. Conte A., Belvisi D., Bologna M., Ottaviani D., Fabbrini G., Colosimo C., et al. Abnormal cortical synaptic plasticity in primary motor area in progressive supranuclear palsy. Cereb Cortex 2012, 22:693-700.
38. Cotelli M., Calabria M., Manenti R., Rosini S., Zanetti O., Cappa S.F., et al. Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry 2011, 82:794-797.
39. Cotelli M., Manenti R., Alberici A., Brambilla M., Cosseddu M., Zanetti O., et al. Prefrontal cortex rTMS enhances action naming in progressive non-fluent aphasia. Eur J Neurol 2012, 19:1404-1412.
40. Cotelli M., Manenti R., Cappa S., Zanetti O., Miniussi C. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur J Neurol 2008, 15:1286-1292.
41. Cotelli M., Manenti R., Cappa S.F., Geroldi C., Zanetti O., Rossini P.M., et al. Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Arch Neurol 2006, 63:1602.
42. Crupi D., Ghilardi M.F., Mosiello C., Di Rocco A., Quartarone A., Battaglia F. Cortical and brainstem LTP-like plasticity in Huntington's disease. Brain Res Bull 2008, 75:107-114.
43. de Carvalho M., de Mendonça A., Miranda P.C., Garcia C., Luís M.L.S. Magnetic stimulation in Alzheimer's disease. J Neurol 1997, 244:304-307.
44. Derejko M., Rakowicz M., Antczak J., Inglot E., Niewiadomska M. Corticomotor excitability in drug-naive patients with Parkinson disease. Neurol Neurochir Pol 2013, 47:109-115.
45. Di Lazzaro V. In vivo assessment of cortical circuitry in CADASIL - a novel biomarker? J Neurol Neurosurg Psychiatry 2013; 84: 241.
46. Di Lazzaro V., Oliviero A., Mazzone P., Pilato F., Saturno E., Insola A., et al. Direct demonstration of long latency cortico-cortical inhibition in normal subjects and in a patient with vascular parkinsonism. Clin Neurophysiol 2002, 113:1673-1679.
47. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., et al. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004, 75:555-559.
48. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 2005, 76:1064-1069.
49. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Meglio M., et al. Direct recording of the output of the motor cortex produced by transcranial magnetic stimulation in a patient with cerebral cortex atrophy. Clin Neurophysiol 2004, 115:112-115.
50. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Tonali PA. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease: evidence of impaired glutamatergic neurotransmission? Ann Neurol 2003; 53: 824.
51. Di Lazzaro V., Oliviero A., Profice P., Meglio M., Cioni B., Tonali P., et al. Descending spinal cord volleys evoked by transcranial magnetic and electrical stimulation of the motor cortex leg area in conscious humans. J Physiol 2001, 537:1047-1058.
52. Di Lazzaro V., Oliviero A., Profice P., Pennisi M., Di Giovanni S., Zito G., et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 2000, 135:455-461.
53. Di Lazzaro V., Oliviero A., Tonali P., Marra C., Daniele A., Profice P., et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 2002, 59:392-397.
54. Di Lazzaro V., Pilato F., Dileone M., Profice P., Marra C., Ranieri F., et al. In vivo functional evaluation of central cholinergic circuits in vascular dementia. Clin Neurophysiol 2008, 119:2494-2500.
55. Di Lazzaro V., Pilato F., Dileone M., Saturno E., Oliviero A., Marra C., et al. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 2006, 66:1111-1113.
56. Di Lazzaro V., Pilato F., Dileone M., Saturno E., Profice P., Marra C., et al. Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage 2007, 37:422-429.
57. Di Lazzaro V., Pilato F., Oliviero A., Dileone M., Saturno E., Mazzone P., et al. Origin of facilitation of motor-evoked potentials after paired magnetic stimulation: direct recording of epidural activity in conscious humans. J Neurophysiol 2006, 96:1765-1771.
58. Di Lazzaro V., Profice P., Pilato F., Dileone M., Oliviero A., Ziemann U. The effects of motor cortex rTMS on corticospinal descending activity. Clin Neurophysiol 2010, 121:464-473.
59. Di Lazzaro V., Restuccia D., Oliviero A., Profice P., Ferrara L., Insola A., et al. Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits. Exp Brain Res 1998, 119:265-268.
60. Di Lorenzo F, Martorana A, Ponzo V, Bonnì S, D'Angelo E, Caltagirone C, et al. Cerebellar theta burst stimulation modulates short latency afferent inhibition in Alzheimer's disease patients. Front Aging Neurosci 2013;5.
61. Dichgans M., Markus H.S., Salloway S., Verkkoniemi A., Moline M., Wang Q., et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008, 7:310-318.
62. Dorsey E.R., George B.P., Leff B., Willis A.W. The coming crisis obtaining care for the growing burden of neurodegenerative conditions. Neurology 2013, 80:1989-1996.
63. Ermolayev V., Cathomen T., Merk J., Friedrich M., Härtig W., Harms G.S., et al. Impaired axonal transport in motor neurons correlates with clinical prion disease. PLoS Pathog 2009, 5:e1000558.
64. Espay A.J., Spina S., Houghton D.J., Murrell J.R., de Courten-Myers G.M., Ghetti B., et al. Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease. J Neurol Neurosurg Psychiatry 2011, 82:751-753.
65. Eusebio A., Azulay J.-P., Witjas T., Rico A., Attarian S. Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation. Clin Neurophysiol 2007, 118:815-823.
66. Fabre I., Galinowski A., Oppenheim C., Gallarda T., Meder J., De Montigny C., et al. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial. Int J Geriat Psychiatry 2004, 19:833-842.
67. Ferbert A., Priori A., Rothwell J., Day B., Colebatch J., Marsden C. Interhemispheric inhibition of the human motor cortex. J Physiol 1992, 453:525-546.
68. Ferreri F., Pasqualetti P., Määttä S., Ponzo D., Guerra A., Bressi F., et al. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation follow-up study. Neurosci Lett 2011, 492:94-98.
69. Ferreri F., Pauri F., Pasqualetti P., Fini R., Dal Forno G, Rossini P.M. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study. Ann Neurol 2003, 53:102-108.
70. Ferreri F., Ponzo D., Hukkanen T., Mervaala E., Könönen M., Pasqualetti P., et al. Human brain cortical correlates of short-latency afferent inhibition: a combined EEG-TMS study. J Neurophysiol 2012, 108:314-323.
71. Filippi M., Agosta F., Barkhof F., Dubois B., Fox N., Frisoni G., et al. EFNS task force. The use of neuroimaging in the diagnosis of dementia. Eur J Neurol 2012, 19:1487-1501.
72. Finocchiaro C., Maimone M., Brighina F., Piccoli T., Giglia G., Fierro B. A case study of primary progressive aphasia: improvement on verbs after rTMS treatment. Neurocase 2006, 12:317-321.
73. Fjell A.M., Walhovd K.B. Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci 2010, 21:187-222.
74. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
75. Frasson E., Bertolasi L., Bertasi V., Fusina S., Bartolomei L., Vicentini S., et al. Paired transcranial magnetic stimulation for the early diagnosis of corticobasal degeneration. Clin Neurophysiol 2003, 114:272-278.
76. Fujimoto K.-I., Sayama S., Shizuma N., Kano M., Nakano I. Intracranial inhibitory mechanisms in clinically diagnosed corticobasal degeneration: a study of a silent period followed by transcranial magnetic stimulation]. Rinshō shinkeigaku. Clin. Neurol. 2000, 40:701.
77. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., et al. Mild cognitive impairment. The Lancet 2006, 367:1262-1270.
78. Golaz J., Bouras C., Hof P.R. Motor cortex involvement in presenile dementia: report of a case. J Geriatr Psychiatry Neurol 1992, 5:85-92.
79. Haffen E., Chopard G., Pretalli J.-B., Magnin E., Nicolier M., Monnin J., et al. A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease. Brain Stimulat 2012, 5:264-266.
80. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000, 406:147-150.
81. Hallett M. Transcranial magnetic stimulation: a primer. Neuron 2007, 55:187-200.
82. Hoeppner J., Wegrzyn M., Thome J., Bauer A., Oltmann I., Buchmann J., et al. Intra-and inter-cortical motor excitability in Alzheimer's disease. J Neural Trans 2012, 119:605-612.
83. Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000; 284: 1664-9.
84. Inghilleri M., Conte A., Frasca V., Scaldaferri N., Gilio F., Santini M., et al. Altered response to rTMS in patients with Alzheimer's disease. Clin Neurophysiol 2006, 117:103-109.
85. Issac T.G., Chandra S.R., Nagaraju B.C. Transcranial magnetic stimulation in patients with early cortical dementia: a pilot study. Ann Ind Acad Neurol 2013, 16:619-622.
86. Jellinger K.A. Neurobiology of cognitive impairment in Parkinson's disease. Expert Rev Neurother 2012, 12:1451-1466.
87. Jorge R.E., Moser D.J., Acion L., Robinson R.G. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008, 65:268.
88. Jorge R.E., Robinson R.G. Treatment of late-life depression: a role of non-invasive brain stimulation techniques. Int Rev Psychiatry 2011, 23:437-444.
89. Josiassen R.C., Curry L., Roemer R.A., Debease C., Mancall E.L. Patterns of intellectual deficit in Huntington's disease. J Clin Exp Neuropsychol 1982, 4:173-183.
90. Julkunen P., Jauhiainen A.M., Westerén-Punnonen S., Pirinen E., Soininen H., Könönen M., et al. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study. J Neurosci Methods 2008, 172:270-276.
91. Jung P., Ziemann U. Homeostatic and nonhomeostatic modulation of learning in human motor cortex. J Neurosci 2009, 29:5597-5604.
92. Kačar A., Filipović S.R., Kresojević N., Milanović S.D., Ljubisavljević M., Kostić V.S., et al. History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease. Clin Neurophysiol 2013, 124:697-707.
93. Khedr E., Ahmed M., Darwish E., Ali A. The relationship between motor cortex excitability and severity of Alzheimer's disease: a transcranial magnetic stimulation study. Neurophysiol Clin/Clin Neurophysiol 2011, 41:107-113.
94. Kobayashi M., Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol 2003, 2:145-156.
95. Koch G., Di Lorenzo F., Bonnì S., Ponzo V., Caltagirone C., Martorana A. Impaired LTP-but not LTD-like cortical plasticity in Alzheimer's disease patients. J Alzheimer's Dis 2012, 31:593-599.
96. Koch G., Esposito Z., Codecà C., Mori F., Kusayanagi H., Monteleone F., et al. Altered dopamine modulation of LTD-like plasticity in Alzheimer's disease patients. Clin Neurophysiol 2011, 122:703-707.
97. Kühn A., Grosse P., Holtz K., Brown P., Meyer B.-U., Kupsch A. Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes. Clin Neurophysiol 2004, 115:1786-1795.
98. Kujirai T., Caramia M., Rothwell J.C., Day B., Thompson P., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 1993, 471:501-519.
99. Lanza G, Bella R, Giuffrida S, Cantone M, Pennisi G, Spampinato C, et al. Preserved transcallosal inhibition to transcranial magnetic stimulation in nondemented elderly patients with leukoaraiosis. BioMed Res Int 2013; 2013.
100. Laxton A.W., Tang-Wai D.F., McAndrews M.P., Zumsteg D., Wennberg R., Keren R., et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol 2010, 68:521-534.
101. Lee S.E., Rabinovici G.D., Mayo M.C., Wilson S.M., Seeley W.W., DeArmond S.J., et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol 2011, 70:327-340.
102. Lefaucheur J.P., Ménard-Lefaucheur I., Maison P., Baudic S., Cesaro P., Peschanski M., et al. Electrophysiological deterioration over time in patients with Huntington's disease. Mov Disord 2006, 21:1350-1354.
103. Leiguarda R.C., Merello M., Nouzeilles M.I., Balej J., Rivero A., Nogués M. Limb-kinetic apraxia in corticobasal degeneration: clinical and kinematic features. Mov Disord 2003, 18:49-59.
104. Lenfeldt N., Larsson A., Nyberg L., Andersson M., Birgander R., Eklund A., et al. Idiopathic normal pressure hydrocephalus: increased supplementary motor activity accounts for improvement after CSF drainage. Brain 2008, 131:2904-2912.
105. Leon-Sarmiento F.E., Rizzo-Sierra C.V., Bayona E.A., Bayona-Prieto J., Doty R.L., Bara-Jimenez W. Novel mechanisms underlying inhibitory and facilitatory transcranial magnetic stimulation abnormalities in Parkinson's disease. Arch Med Res 2013, 44:221-228.
106. Leroi I., McDonald K., Pantula H., Harbishettar V. Cognitive impairment in Parkinson disease impact on quality of life, disability, and caregiver burden. J Geriatr Psychiatry Neurol 2012, 25:208-214.
107. Liepert J., Bär K., Meske U., Weiller C. Motor cortex disinhibition in Alzheimer's disease. Clin Neurophysiol 2001, 112:1436-1441.
108. Lillo P., Mioshi E., Burrell J.R., Kiernan M.C., Hodges J.R., Hornberger M. Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One 2012, 7:e43993.
109. Lindenbach D., Bishop C. Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease. Neurosci Biobehav Rev 2013, 37:2737-2750.
110. List J., Duning T., Meinzer M., Kürten J., Schirmacher A., Deppe M., et al. Enhanced rapid-onset cortical plasticity in CADASIL as a possible mechanism of preserved cognition. Cereb Cortex 2011, 21:2774-2787.
111. List J., Duning T., Meinzer M., Kürten J., Schirmacher A., Deppe M., et al. Enhanced rapid-onset cortical plasticity in CADASIL as a possible mechanism of preserved cognition. Cereb Cortex 2011, 21:2774-2787.
112. Lorenzano C., Dinapoli L., Gilio F., Suppa A., Bagnato S., Currà A., et al. Motor cortical excitability studied with repetitive transcranial magnetic stimulation in patients with Huntington's disease. Clin Neurophysiol 2006, 117:1677-1681.
113. Löscher W.N., Stampfer-Kountchev M., Sawires M., Seppi K., Mueller J., Szubski C., et al. Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophy. Mov Disord 2007, 22:174-178.
114. Lu C., Ikeda A., Terada K., Mima T., Nagamine T., Fukuyama H., et al. Electrophysiological studies of early stage corticobasal degeneration. Mov Disord 1998, 13:140-146.
115. Manganelli F., Ragno M., Cacchiò G., Iodice V., Trojano L., Silvaggio F., et al. Motor cortex cholinergic dysfunction in CADASIL: a transcranial magnetic demonstration. Clin Neurophysiol 2008, 119:351-355.
116. Manganelli F., Vitale C., Santangelo G., Pisciotta C., Iodice R., Cozzolino A., et al. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Brain 2009, 132:2350-2355.
117. Marchese R., Trompetto C., Buccolieri A., Abbruzzese G. Abnormalities of motor cortical excitability are not correlated with clinical features in atypical parkinsonism. Mov Disord 2000, 15:1210-1214.
118. Marra C., Quaranta D., Profice P., Pilato F., Capone F., Iodice F., et al. Central cholinergic dysfunction measured "in vivo" correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body. Brain Stimul 2012, 5:533-538.
119. Marra C., Quaranta D., Profice P., Pilato F., Capone F., Iodice F., et al. Central cholinergic dysfunction measured "in vivo" correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body. Brain Stimulat 2012, 5:533-538.
120. Marras A, Pallanti S. Transcranial magnetic stimulation for the treatment of pharmacoresistant nondelusional auditory verbal hallucinations in dementia. Case Rep Psychiatry 2013;2013.
121. Martinez A.C., Arpa J., Alonso M., Palomo F., Villoslada C. Transcranial magnetic stimulation in multiple system and late onset cerebellar atrophies. Acta Neurol Scand 1995, 92:218-224.
122. Martorana A, Di Lorenzo F, Esposito Z, Lo Giudice T, Bernardi G, Caltagirone C, et al. Dopamine D2-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients. Neuropharmacology 2013; 64: 108-13.
123. Martorana A., Mori F., Esposito Z., Kusayanagi H., Monteleone F., Codecà C., et al. Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacology 2009, 34:2323-2328.
124. Martorana A., Stefani A., Palmieri M.G., Esposito Z., Bernardi G., Sancesario G., et al. L-dopa modulates motor cortex excitability in Alzheimer's disease patients. J Neural Transm 2008, 115:1313-1319.
125. Mascia M., Valls-Solé J., Martí M., Salazar G. Sensorimotor integration in patients with parkinsonian type multisystem atrophy. J Neurol 2005, 252:473-481.
126. McDonnell M.N., Orekhov Y., Ziemann U. The role of GABAB receptors in intracortical inhibition in the human motor cortex. Exp Brain Res 2006, 173:86-93.
127. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
128. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939.
129. Meyer B.-U., Noth J., Lange H.W., Bischoff C., Machetanz J., Weindl A., et al. Motor responses evoked by magnetic brain stimulation in Huntington's disease. Electroencephal Clin Neurophysiol/Evok Potent Sect 1992, 85:197-208.
130. Meyer B.-U., Röricht S., Von Einsiedel H.G., Kruggel F., Weindl A. Inhibitory and excitatory interhemispheric transfers between motor cortical areas in normal humans and patients with abnormalities of the corpus callosum. Brain 1995, 118:429-440.
131. Mioshi E., Hodges J. Rate of change of functional abilities in frontotemporal dementia. Dement Geriatr Cogn Disord 2009, 28:419-426.
132. Modugno N., Curra A., Giovannelli M., Priori A., Squitieri F., Ruggieri S., et al. The prolonged cortical silent period in patients with Huntington's disease. Clin Neurophysiol 2001, 112:1470-1474.
133. Morita Y., Osaki Y. Transcranial magnetic stimulation for differential diagnostics in patients with parkinsonism. Acta Neurol Scand 2008, 118:159-163.
134. Murakami T., Müller-Dahlhaus F., Lu M.K., Ziemann U. Homeostatic metaplasticity of corticospinal excitatory and intracortical inhibitory neural circuits in human motor cortex. J Physiol 2012, 590:5765-5781.
135. Nagao S., Yokota O., Nanba R., Takata H., Haraguchi T., Ishizu H., et al. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia. J Neurol Sci 2012, 323:147-153.
136. Nardone R., Bergmann J., Brigo F., Christova M., Kunz A., Seidl M., et al. Functional evaluation of central cholinergic circuits in patients with Parkinson's disease and REM sleep behavior disorder: a TMS study. J Neural Transm 2013, 120:413-422.
137. Nardone R., Bergmann J., Christova M., Caleri F., Tezzon F., Ladurner G., et al. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment. J Neural Transm 2012, 119:463-471.
138. Nardone R., Bergmann J., De Blasi P., Kronbichler M., Kraus J., Caleri F., et al. Cholinergic dysfunction and amnesia in patients with Wernicke-Korsakoff syndrome: a transcranial magnetic stimulation study. J Neural Transm 2010, 117:385-391.
139. Nardone R., Bergmann J., Kronbichler M., Kunz A., Klein S., Caleri F., et al. Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration. J Neural Transm 2008, 115:1557-1562.
140. Nardone R., Bergmann J., Tezzon F., Ladurner G., Golaszewski S. Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study. J Neural Transm 2008, 115:737-743.
141. Nardone R., Bratti A., Tezzon F. Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease. J Neural Transm 2006, 113:1679-1684.
142. Nardone R., Florio I., Lochner P., Tezzon F. Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. Exp Brain Res 2005, 163:128-131.
143. Nardone R., Lochner P., Marth R., Ausserer H., Bratti A., Tezzon F. Abnormal intracortical facilitation in early-stage Huntington's disease. Clin Neurophysiol 2007, 118:1149-1154.
144. Nardone R., Venturi A., Buffone E., Covi M., Florio I., Lochner P., et al. Transcranial magnetic stimulation shows impaired transcallosal inhibition in Marchiafava-Bignami syndrome. Eur J Neurol 2006, 13:749-753.
145. Ni Z., Bahl N., Gunraj C.A., Mazzella F., Chen R. Increased motor cortical facilitation and decreased inhibition in Parkinson disease. Neurology 2013, 80:1746-1753.
146. Niskanen E., Könönen M., Määttä S., Hallikainen M., Kivipelto M., Casarotto S., et al. New insights into Alzheimer's disease progression: a combined TMS and structural MRI study. PLoS One 2011, 6:e26113.
147. Nolano M., Guardascione M., Amitrano L., Perretti A., Fiorillo F., Ascione A., et al. Cortico-spinal pathways and inhibitory mechanisms in hepatic encephalopathy. Electroencephalogr Clin Neurophysiol/Electromyogr Mot Contr 1997, 105:72-78.
148. Ohnari K., Matsunaga K., Uozumi T., Tamagawa A., Hashimoto T., Tsuji S. Unilateral positive-negative myoclonus in Creutzfeldt-Jakob disease. Mov Disord 2006, 21:1963-1966.
149. Okuma Y., Urabe T., Mochizuki H., Miwa H., Shimo Y., Mori H., et al. Asymmetric cortico-cortical inhibition in patients with progressive limb-kinetic apraxia. Acta Neurol Scand 2000, 102:244-248.
150. Olazarán J., Hernández-Tamames J.A., Molina E., García-Polo P., Dobato J.L., Álvarez-Linera J., et al. Clinical and anatomical correlates of gait dysfunction in Alzheimer's disease. J Alzheimer's Dis 2013, 33:495-505.
151. Olazarán J., Prieto J., Cruz I., Esteban A. Cortical excitability in very mild Alzheimer's disease: a long-term follow-up study. J Neurol 2010, 257:2078-2085.
152. Palomar F.J., Suárez A., Franco E., Carrillo F., Gil-Néciga E., Mir P. Abnormal sensorimotor plasticity in CADASIL correlates with neuropsychological impairment. J Neurol Neurosurg Psychiatry 2013, 84:329-336.
153. Papp M., Lantos P. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994, 117:235-243.
154. Parisi L., Terracciano M., Valente G., Calandriello E., Accorinti M., Spadaro M. Pre-symptomatic neurological involvement in Behçet's disease: the diagnostic role of magnetic transcranial stimulation. Electroencephalogr Clin Neurophysiol/Electromyogr Mot Contr 1996, 101:42-47.
155. Parvizi J., Anderson S.W., Martin C.O., Damasio H., Damasio A.R. Pathological laughter and crying A link to the cerebellum. Brain 2001, 124:1708-1719.
156. Paula-Lima A.C., Brito-Moreira J., Ferreira S.T. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease. J Neurochem 2013, 126:191-202.
157. Paulus W., Classen J., Cohen L.G., Large C.H., Di Lazzaro V., Nitsche M., et al. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimul 2008, 1:151-163.
158. Pennimpede G, Spedaliere L, Formica D, Di Pino G, Zollo L, Pellegrino G, et al. Hot spot hound: a novel robot-assisted platform for enhancing TMS performance. Engineering in Medicine and Biology Society (EMBC), 2013 35th annual international conference of the IEEE: IEEE; 2013. p. 6301-4.
159. Pennisi G., Alagona G., Ferri R., Greco S., Santonocito D., Pappalardo A., et al. Motor cortex excitability in Alzheimer disease: one year follow-up study. Neurosci Lett 2002, 329:293-296.
160. Pennisi G., Ferri R., Alagona G., Pennisi M., Malaguarnera G., Motta M., et al. Motor cortex hyperexcitability in subcortical ischemic vascular dementia. Arch Gerontol Geriatr 2011, 53:e111-e113.
161. Pennisi G., Ferri R., Lanza G., Cantone M., Pennisi M., Puglisi V., et al. Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability. J Neural Transm 2011, 118:587-598.
162. Pepin J.L., Bogacz D., de Pasqua V., Delwaide P.J. Motor cortex inhibition is not impaired in patients with Alzheimer's disease: evidence from paired transcranial magnetic stimulation. J Neurol Sci 1999, 170:119-123.
163. Perretti A., Grossi D., Fragassi N., Lanzillo B., Nolano M., Pisacreta A., et al. Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer disease. J Neurol Sci 1996, 135:31-37.
164. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256:183-194.
165. Pierantozzi M., Panella M., Palmieri M., Koch G., Giordano A., Marciani M., et al. Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia. Clin Neurophysiol 2004, 115:2410-2418.
166. Rabey J.M., Dobronevsky E., Aichenbaum S., Gonen O., Marton R.G., Khaigrekht M. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study. J Neural Transm 2012, 1-7.
167. Ravaglia S., Costa A., Ratti M.T., Savoldi F., Bo P., Moglia A. Cognitive impairment and central motor conduction time in chronic alcoholics. Funct Neurol 2002, 17:83-86.
168. Reedeker W., van der Mast R., Giltay E., Kooistra T., Roos R., van Duijn E. Psychiatric disorders in Huntington's disease: a 2-year follow-up study. Psychosomatics 2012, 53:220-229.
169. Rektorova I., Megova S., Bares M., Rektor I. Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients. J Neurol Sci 2005, 229:157-161.
170. Ridding M., Rothwell J., Inzelberg R. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995, 37:181-188.
171. Román G.C., Erkinjuntti T., Wallin A., Pantoni L., Chui H.C. Subcortical ischaemic vascular dementia. Lancet Neurol 2002, 1:426-436.
172. Röricht S., Meyer B.-U., Woiciechowsky C., Lehmann R. Callosal and corticospinal tract function in patients with hydrocephalus: a morphometric and transcranial magnetic stimulation study. J Neurol 1998, 245:280-288.
173. Rosas H.D., Salat D.H., Lee S.Y., Zaleta A.K., Pappu V., Fischl B., et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008, 131:1057-1068.
174. Rosenbloom M.H., Atri A. The evaluation of rapidly progressive dementia. Neurologist 2011, 17:67-74.
175. Rossi Sebastiano D, Soliveri P, Panzica F, Moroni I, Gellera C, Gilioli I, et al. Cortical myoclonus in childhood and juvenile onset Huntington's disease. Parkinsonism Relat Disord 2012;18:794-7.
176. Rossini P., Barker A., Berardelli A., Caramia M., Caruso G., Cracco R., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994, 91:79-92.
177. Rossini P.M., Rossi S., Babiloni C., Polich J. Clinical neurophysiology of aging brain: from normal aging to neurodegeneration. Prog Neurobiol 2007, 83:375-400.
178. Sailer A., Molnar G.F., Paradiso G., Gunraj C.A., Lang A.E., Chen R. Short and long latency afferent inhibition in Parkinson's disease. Brain 2003, 126:1883-1894.
179. Sakuishi K., Hanajima R., Kanazawa I., Ugawa Y. Periodic motor cortical excitability changes associated with PSDs of EEG in Creutzfeldt-Jakob disease (CJD). Clin Neurophysiol 2005, 116:1222-1226.
180. Sakuma K., Murakami T., Nakashima K. Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin Neurophysiol 2007, 118:1460-1463.
181. Sanchez P.E., Zhu L., Verret L., Vossel K.A., Orr A.G., Cirrito J.R., et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc Natl Acad Sci U S A 2012, 109:E2895-E2903.
182. Sax D.S., Powsner R., Kim A., Tilak S., Bhatia R., Cupples L.A., et al. Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov Disord 1996, 11:671-677.
183. Schippling S., Schneider S.A., Bhatia K.P., Münchau A., Rothwell J.C., Tabrizi S.J., et al. Abnormal motor cortex excitability in preclinical and very early Huntington's disease. Biol Psychiatry 2009, 65:959-965.
184. Shirota Y., Hamada M., Hanajima R., Terao Y., Matsumoto H., Ohminami S., et al. Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study. Mov Disord 2010, 25:2413-2419.
185. Shukla C., Bridges L.R. Regional distribution of tau, [beta]-amyloid and [beta]-amyloid precursor protein in the Alzheimer's brain: a quantitative immunolabelling study. NeuroReport 1999, 10:3785-3789.
186. Siebner H.R., Dressnandt J., Auer C., Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 1998, 21:1209-1212.
187. Sosa-Ortiz A.L., Acosta-Castillo I., Prince M.J. Epidemiology of dementias and Alzheimer's disease. Arch Med Res 2012, 43:600-608.
188. Spagnolo F., Coppi E., Chieffo R., Straffi L., Fichera M., Nuara A., et al. Interhemispheric balance in Parkinson's disease: a transcranial magnetic stimulation study. Brain Stimul 2013, 6:892-897.
189. Spampinato C., Aguglia E., Concerto C., Pennisi M., Lanza G., Bella R., et al. Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drug-resistant major depression. IEEE Trans Neural Syst Rehabil Eng 2013, 21:391-403.
190. Stefan K., Kunesch E., Cohen L.G., Benecke R., Classen J. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain 2000, 123:572-584.
191. Stigsby B., Bohlega S., McLean D.R., Al-Kawi M.Z. Transcranial magnetic stimulation in Behçet's disease: a cross-sectional and longitudinal study with 44 patients comparing clinical, neuroradiological, somatosensory and brain-stem auditory evoked potential findings. Clin Neurophysiol 2000, 111:1320-1329.
192. Suppa A., Marsili L., Di Stasio F., Latorre A., Parvez A., Colosimo C., et al. Primary motor cortex long-term plasticity in multiple system atrophy. Movement Disord 2013, 29:97-104.
193. Suppa A., Marsili L., Di Stasio F., Latorre A., Parvez A.K., Colosimo C., et al. Primary motor cortex long-term plasticity in multiple system atrophy. Mov Disord 2014, 29:97-104.
194. Suvà D., Favre I., Kraftsik R., Esteban M., Lobrinus A., Miklossy J. Primary motor cortex involvement in Alzheimer disease. J Neuropathol Exp Neurol 1999, 58:1125-1134.
195. Tabaraud F., Hugon J., Salle J., Boulesteix J., Rigaud M., Vallat J., et al. Central motor conduction and glutamate deshydrogenase: activity in olivo-ponto-cerebellar atrophy. Clin Neurophysiol 1989, 19:433-441.
196. Taipa R, Pinho J, Melo-Pires M. Clinico-pathological correlations of the most common neurodegenerative dementias. Front Neurol 2012;3.
197. Takahashi R., Ishii K., Shimada K., Ohkawa S., Nishimura Y. Hypoperfusion of the motor cortex associated with parkinsonism in dementia with Lewy bodies. J Neurol Sci 2010, 288:88-91.
198. Taylor J.-P., Firbank M., Barnett N., Pearce S., Livingstone A., Mosimann U., et al. Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study. Brit J Psychiatry 2011, 199:492-500.
199. Terranova C., Carmen T., SantAngelo A., Antonino S.A., Morgante F., Francesca M., et al. Impairment of sensory-motor plasticity in mild Alzheimer's disease. Brain Stimul 2013, 6:62-66.
200. Thompson J.C., Harris J., Sollom A.C., Stopford C.L., Howard E., Snowden J.S., et al. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. J Neuropsychiatry Clin Neurosci 2012, 24:53-60.
201. Thu D.C., Oorschot D.E., Tippett L.J., Nana A.L., Hogg V.M., Synek B.J., et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 2010, 133:1094-1110.
202. Tiraboschi P, Hansen L, Alford M, Sabbagh M, Schoos B, Masliah E, et al. Cholinergic dysfunction in diseases with Lewy bodies. Neurology 2000;54:407.
203. Tokimura H., Lazzaro V., Tokimura Y., Oliviero A., Profice P., Insola A., et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 2000, 523:503-513.
204. Trebbastoni A., Gilio F., D'Antonio F., Cambieri C., Ceccanti M., de Lena C., et al. Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5Hz-repetitive transcranial magnetic stimulation. Clin Neurophysiol 2012, 123:902-909.
205. Trebbastoni A., Raccah R., de Lena C., Zangen A., Inghilleri M. Repetitive deep transcranial magnetic stimulation improves verbal fluency and written language in a patient with primary progressive aphasia-logopenic variant (LPPA). Brain Stimul 2012, 6:545-553.
206. Trebbastoni A., Raccah R., de Lena C., Zangen A., Inghilleri M. Repetitive deep transcranial magnetic stimulation improves verbal fluency and written language in a patient with primary progressive aphasia-logopenic variant (LPPA). Brain Stimul 2013, 6:545-553.
207. Trompetto C., Buccolieri A., Marchese R., Marinelli L., Michelozzi G., Abbruzzese G. Impairment of transcallosal inhibition in patients with corticobasal degeneration. Clin Neurophysiol 2003, 114:2181-2187.
208. Valls-Solé J. Neurophysiological characterization of parkinsonian syndromes. Neurophysiol Clin/Clin Neurophysiol 2000, 30:352-367.
209. Van der Flier W., Scheltens P. Use of laboratory and imaging investigations in dementia. J Neurol Neurosurg Psychiatry 2005, 76:v45-v52.
210. Vidoni E.D., Thomas G.P., Honea R.A., Loskutova N., Burns J.M. Evidence of altered corticomotor system connectivity in early-stage Alzheimer's disease. J Neurol Phys Ther 2012, 36:8.
211. Wang H., Wang X., Scheich H. LTD and LTP induced by transcranial magnetic stimulation in auditory cortex. NeuroReport 1996, 7:521-525.
212. Wegrzyn M., Teipel S.J., Oltmann I., Bauer A., Thome J., Großmann A., et al. Structural and functional cortical disconnection in Alzheimer's disease: a combined study using diffusion tensor imaging and transcranial magnetic stimulation. Psychiatry Res Neuroimaging 2012, 212:192-200.
213. Wegrzyn M., Teipel S.J., Oltmann I., Bauer A., Thome J., Großmann A., et al. Structural and functional cortical disconnection in Alzheimer's disease: a combined study using diffusion tensor imaging and transcranial magnetic stimulation. Psychiatry Res 2013, 212:192-200.
214. Weiner M.W. Dementia in 2012: further insights into Alzheimer disease pathogenesis. Nat Rev Neurol 2013, 9:65-66.
215. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol 1999, 517:591-597.
216. Whitwell J., Jack C., Boeve B., Parisi J., Ahlskog J., Drubach D., et al. Imaging correlates of pathology in corticobasal syndrome. Neurology 2010, 75:1879-1887.
217. Wittstock M., Pohley I., Walter U., Grossmann A., Benecke R., Wolters A. Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy. J Neural Transm 2013, 120:453-461.
218. Wochnik-Dyjas D., Niewiadomska M., Kulczycki J., Łojkowska W., Niedzielska K., Głazowski C., et al. Motor evoked potential studies in Creutzfeldt-Jakob disease. Clin Neurophysiol 2000, 111:1687-1694.
219. Wolters A., Classen J., Kunesch E., Grossmann A., Benecke R. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes. Mov Disord 2004, 19:518-528.
220. Wu T., Sommer M., Tergau F., Paulus W. Lasting influence of repetitive transcranial magnetic stimulation on intracortical excitability in human subjects. Neurosci Lett 2000, 287:37-40.
221. Yamout K., Goldstein F.C., Lah J.J., Levey A.I., Bliwise D.L. Neurocognitive correlates of nocturnal oxygen desaturation in a memory clinic population. J Clin Exp Neuropsychol 2012, 34:325-332.
222. Yarnall A.J., Rochester L., Baker M.R., David R., Khoo T.K., Duncan G.W., et al. Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?. Mov Disord 2013, 28:1285-1288.
223. Yokota T., Yoshino A., Hirashima F., Komori T., Miyatake T. Increased central motor tract excitability in Creutzfeldt-Jakob disease. J Neurol Sci 1994, 123:33-37.
224. Zarei M., Ibarretxe-Bilbao N., Compta Y., Hough M., Junque C., Bargallo N., et al. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2013, 84:875-881.
225. Ziemann U. TMS and drugs. Clin Neurophysiol 2004, 115:1717-1729.
226. Ziemann U., Lönnecker S., Steinhoff B., Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996, 40:367-378.